Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

NCT02027805 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xenikos